Search

everythinglearnresearchcommunity

for

Search:↓

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

A20 protein is crucial for normal skin and hair development.

Advanced human skin models improve drug development and could replace animal testing.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Enzymes called PADIs play a key role in hair growth and loss.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

New therapies are being developed that target integrin pathways to treat various diseases.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.